| Primary reference | Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases., He X, Da Ros S, Nelson J, Zhu X, Jiang T, Okram B, Jiang S, Michellys PY, Iskandar M, Espinola S, Jia Y, Bursulaya B, Kreusch A, Gao MY, Spraggon G, Baaten J, Clemmer L, Meeusen S, Huang D, Hill R, Nguyen-Tran V, Fathman J, Liu B, Tuntland T, Gordon P, Hollenbeck T, Ng K, Shi J, Bordone L, Liu H, ACS Med Chem Lett. 2017 Sep 27;8(10):1048-1053. doi:, 10.1021/acsmedchemlett.7b00258. eCollection 2017 Oct 12. PMID:29057049 |